These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Transgenic nonhuman primate models for human diseases: approaches and contributing factors. Chen Y, Niu Y, Ji W. J Genet Genomics; 2012 Jun 20; 39(6):247-51. PubMed ID: 22749011 [Abstract] [Full Text] [Related]
3. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms]. Šaponjić J. Glas Srp Akad Nauka Med; 2011 Jun 20; (51):85-97. PubMed ID: 22165729 [Abstract] [Full Text] [Related]
5. Genetically modified pig models for neurodegenerative disorders. Holm IE, Alstrup AK, Luo Y. J Pathol; 2016 Jan 01; 238(2):267-87. PubMed ID: 26446984 [Abstract] [Full Text] [Related]
6. Nature, nurture and neurology: gene-environment interactions in neurodegenerative disease. FEBS Anniversary Prize Lecture delivered on 27 June 2004 at the 29th FEBS Congress in Warsaw. Spires TL, Hannan AJ. FEBS J; 2005 May 01; 272(10):2347-61. PubMed ID: 15885086 [Abstract] [Full Text] [Related]
7. Transgenic animal models of neurodegenerative diseases and their application to treatment development. Rockenstein E, Crews L, Masliah E. Adv Drug Deliv Rev; 2007 Sep 30; 59(11):1093-102. PubMed ID: 17869376 [Abstract] [Full Text] [Related]
8. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA. J Neurol Sci; 2005 Jun 15; 233(1-2):145-62. PubMed ID: 15896810 [Abstract] [Full Text] [Related]
9. Transgenic Animal Models of Huntington's Disease. Yang SH, Chan AW. Curr Top Behav Neurosci; 2011 Jun 15; 7():61-85. PubMed ID: 21225414 [Abstract] [Full Text] [Related]
10. Progress and prospects for genetic modification of nonhuman primate models in biomedical research. Chan AW. ILAR J; 2013 Jun 15; 54(2):211-23. PubMed ID: 24174443 [Abstract] [Full Text] [Related]
11. Genetic mouse models of neurodegenerative diseases. Trancikova A, Ramonet D, Moore DJ. Prog Mol Biol Transl Sci; 2011 Jun 15; 100():419-82. PubMed ID: 21377633 [Abstract] [Full Text] [Related]
12. Application of MRS to mouse models of neurodegenerative illness. Choi JK, Dedeoglu A, Jenkins BG. NMR Biomed; 2007 May 15; 20(3):216-37. PubMed ID: 17451183 [Abstract] [Full Text] [Related]
13. Behavioral phenotyping of mouse models of neurodegeneration. Dumont M. Methods Mol Biol; 2011 May 15; 793():229-37. PubMed ID: 21913104 [Abstract] [Full Text] [Related]
14. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned model of parkinson's disease, with emphasis on mice and nonhuman primates. Jakowec MW, Petzinger GM. Comp Med; 2004 Oct 15; 54(5):497-513. PubMed ID: 15575363 [Abstract] [Full Text] [Related]
15. Mechanisms of Disease: astrocytes in neurodegenerative disease. Maragakis NJ, Rothstein JD. Nat Clin Pract Neurol; 2006 Dec 15; 2(12):679-89. PubMed ID: 17117171 [Abstract] [Full Text] [Related]
16. The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future. Fox SH, Brotchie JM. Prog Brain Res; 2010 Dec 15; 184():133-57. PubMed ID: 20887873 [Abstract] [Full Text] [Related]
17. From fruit fly to bedside: translating lessons from Drosophila models of neurodegenerative disease. Shulman JM, Shulman LM, Weiner WJ, Feany MB. Curr Opin Neurol; 2003 Aug 15; 16(4):443-9. PubMed ID: 12869801 [Abstract] [Full Text] [Related]